Popular

Having trouble identifying your medications? Try the Pill Identifier

Quickly identify pills, tablets and capsules using the web's most comprehensive Pill Identification Wizard.

Get Started

Featured Tool

Worried about drug interactions? Use the Interactions Checker

The drug interactions tool allows you to check for drug-drug and drug-food interactions.

Check Now

Featured Tool

Discover treatment options with the new Symptom Checker

This interactive decision guide helps identify the underlying cause of common symptoms.

Get Started

Featured Tool

Custom search for Medical Transcriptionists?

Use our custom wildcard and phonetic search to assist in identifying drugs where the exact spelling is unknown and only the pronunciation is available.

Get Started

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

Posted today in New Drug Applications

ZS Pharma Submits NDA for ZS-9 for the Treatment of Hyperkalemia

ZS Pharma, Inc. (Nasdaq:ZSPH), a biopharmaceutical company focused on the development and commercialization of highly selective, non-absorbed drugs to treat renal, cardiovascular, liver and metabolic disorders, today announced that it has submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for ZS-9 (sodium...

Posted today in Clinical Trials

Pivotal Study Results Showed Talimogene Laherparepvec Improved Durable Response Rates in Patients With Metastatic Melanoma

Amgen (NASDAQ: AMGN) today announced the publication of primary results from the Phase 3 OPTiM study in the Journal of Clinical Oncology (JCO). The data published in JCO, which were previously presented at the Annual Meetings of the American Society of Clinical Oncology (ASCO) in 2013 and 2014, demonstrated a significantly higher durable response rate...

Posted today in Medical

Health Tip: Reducing Your Risk of Motion Sickness

-- The dizzy, nauseous and uncomfortable sensations of motion sickness can make travel unbearable. The Cleveland Clinic recommends: Don't read in a moving vehicle. Before traveling, make sure you are well-rested. Drink plenty of water, and avoid alcohol and smoking. Also, avoid greasy foods. If possible, stand up and look out at the horizon. Nibble...

Posted today in New Drug Approvals

FDA Approves Stiolto Respimat (tiotropium bromide and olodaterol) Inhalation Spray for COPD

RIDGEFIELD, Conn., May 26, 2015 – Boehringer Ingelheim today announced that the U.S. Food and Drug Administration (FDA) approved once-daily Stiolto Respimat (tiotropium bromide and olodaterol) Inhalation Spray. It has been approved as a long-term, once-daily maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary...

Posted today in Medical

Health Highlights: May 26, 2015

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: GMO-Free Similac Advance Baby Formula Announced Similac Advance baby formula made without genetically altered ingredients will be available by the end of the month in Target stores, according to product maker Abbott. That will make Similac Advance...

Posted today in Medical

Soy Supplements Won't Ease Asthma, Study Finds

Despite hints from prior research that soy supplements might help asthma patients breathe easier, a major new study finds the nutrient has no beneficial effect on lung function. "This study highlights why it is so important to perform well-designed, placebo-controlled studies when associations are reported between specific nutrients and disease outcomes,"...

Posted today in Medical

Potential Ebola Drug Target Identified in Mouse Study

Researchers working with rodents say they've pinpointed a potential target for drugs to fight Ebola. Studies with mice revealed that a protein called Niemann-Pick C1 (NPC1) plays a critical role in Ebola's ability to infect a host. Drugs that block this protein might prove effective against the deadly disease, according to the authors of the study...

Posted today in Medical

Fewer U.S. Hospitals Send New Moms Home With Formula

While the percentage of hospitals that send breast-feeding mothers home with formula packs has fallen dramatically during the last several years, about one-third of U.S. hospitals still do so, newly released data shows. The formula packs usually contain infant formula samples, infant formula coupons, advertising materials and other baby products. "Several...

Posted today in Medical

'Moderate'Drinking Might Harm Older People's Hearts: Study

"Moderate" drinking might harm your heart if you're a senior citizen, a new study suggests. And women appear to be at greater risk for alcohol-related heart damage than men, the researchers found. "In an elderly population, increasing alcohol intake is associated with subtle alterations in heart structure and function, with women appearing more susceptible...

Posted today in Medical

Delaying Umbilical Cord Clamping Might Boost Child Development

Waiting about three minutes to clamp the umbilical cord following a baby's delivery may help improve children's fine-motor and social skills at age 4 years, new Swedish research suggests. The researchers said postponing the clamping of the cord allows continued flow of fetal blood from the placenta to the newborn. This, in turn, appears to be tied...

Read more news...

Recently added consumer and prescribing information: Kybella, Corlanor, Cresemba, Zarxio, Farydak, Lenvima, Ibrance, Glyxambi, Evotaz, Prezcobix

Posted in Blog

Harnessing the Power of the Poliovirus as a Cancer Cure

Polio, a highly infectious and crippling disease, was certainly one of the most feared viruses in the 20th century. Each year, thousands of children were left paralyzed. Polio has been successfully eliminated in the U.S. for decades due to a widespread vaccine program. So why would a group of researchers be interested in injecting the […]

Posted in Blog

Biosimilars in 2015: What Can We Expect?

On Friday, March 6th, 2015 the FDA approved Sandoz’s Zarxio, the first official biosimilar that will be made available in the U.S. Zarxio, a recombinant granulocyte colony-stimulating factor used to boost white blood cells after cancer treatments, is the long-awaited biosimilar for filgrastim (Amgen’s Neupogen). The FDA noted in their briefs that Zarxio was “highly […]

Posted in Blog

Drugs.com Adds Mayo Clinic Disease Reference

Drugs.com is pleased to announce it has licensed select content from Mayo Clinic to provide more timely and trustworthy medical condition and disease information. The articles include detailed information about medical diseases such as allergies, back pain, depression, erectile dysfunction, and type 2 diabetes. Each article includes informative sections which may include an overview, symptoms, when […]

See more blog posts or follow us on twitter.

Hide
(web3)